BioAge Labs Balance Sheet Health
Financial Health criteria checks 5/6
BioAge Labs has a total shareholder equity of $313.7M and total debt of $9.9M, which brings its debt-to-equity ratio to 3.2%. Its total assets and total liabilities are $337.4M and $23.6M respectively.
Key information
3.2%
Debt to equity ratio
US$9.94m
Debt
| Interest coverage ratio | n/a |
| Cash | US$334.47m |
| Equity | US$313.75m |
| Total liabilities | US$23.63m |
| Total assets | US$337.38m |
Recent financial health updates
No updates
Recent updates
No updates
Financial Position Analysis
Short Term Liabilities: Y7G's short term assets ($336.5M) exceed its short term liabilities ($19.1M).
Long Term Liabilities: Y7G's short term assets ($336.5M) exceed its long term liabilities ($4.6M).
Debt to Equity History and Analysis
Debt Level: Y7G has more cash than its total debt.
Reducing Debt: Insufficient data to determine if Y7G's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Y7G has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Y7G has sufficient cash runway for 2.6 years if free cash flow continues to reduce at historical rates of 22.2% each year.